Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
MEDIA ALERT: ESSENCE & The U.S. Black Chambers Join to Provide Black Entrepreneurs and Businesses With Information on COVID-19 Relief Under the New Cares Act
-
Artificial Madness: Stats Perform Uses Proprietary AI Model to Simulate What Could Have Been During the NCAA Tournament
-
CRA International (CRAI) Announces Richard D. Booth to Board
-
Abeona Therapeutics (ABEO) Reports First Patient Treatment in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
-
Zymeworks (ZYME) Announces Dr. Kelvin Neu to Board
-
Stanford Online High School Offering Free Resources for Schools Closing Amid Coronavirus Fears
-
Win The Storm Conference Features Home Repair CEO Tony Silva on Expert Panel
-
Stanford Team Releases RaceWorks, a Digital Toolkit Promoting Racial Literacy
-
Enphase Energy (ENPH) Adds Joseph Malchow to Board
-
Global Data Solution Provider Syniti Names Industry and Region Veteran Jules Beck as President Europe & Africa; Clive Bellmore as Chairman
-
Invasion 2020 Marches Back into San Francisco
-
BridgeBio Pharma Inc. (BBIO) Announces Ronald J. Daniels to Board
-
Corteva (CTVA) Announces Nayaki Nayyar to Board
-
Stanford Graduate School of Business Sports Innovation Conference Returns February 26 with High Profile Lineup
-
Pennymac Financial Services (PFSI) Announces Transfer of Ownership Stake by BlackRock to Charitable Entities
-
Kodiak Sciences Inc. (KOD) Reports Promising Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet DME & RVO
-
JanOne (JAN) executes manufacturing agreement for formulation and manufacturing of TV1001SR
-
Stanford Children's Health Welcomes Two New Executive Leaders in 2020
-
Materion Corp. (MTRN) Names Emily Liggett to Board
-
Levi (LEVI) Names Yael Garten to Board
-
Vislink Technologies Inc. (VISL) Names Brian Krolicki to Board
-
YayYo (YAYO) announces CEO Jonathan Rosen has resigned
-
Alpine Immune Sciences (ALPN) Presents New Preclinical Data at 2020 Crohn’s & Colitis Congress
-
Tiptree Financial (TIPT) Announces Dominique Mielle to Board
-
Model N Inc. (MODN) Announces Kimberly DeCarlis to Board
-
Prologis (PLD) Appoints Avid Modjtabai to Board; Announces Philip L. Hawkins to Step Down from Board
-
Stanford ICME Announces WiDS Datathon to Predict ICU Mortality
-
Abeona Therapeutics (ABEO) Begins Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
-
MasterCard (MA) Announces Raj Seshadri Named President, Data & Services
-
Travelers Hosts Industry Discussion on the Future of Insurance and Autonomous Vehicles
-
Stanford Medicine's 2020 Health Trends Report spotlights the rise of the data-driven physician
-
IBM (IBM) Says It's Working with Over 100 Organizations to Advance Practical Quantum Computing
-
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
-
Vislink Technologies Inc. (VISL) Appoints Ralph Faison to its Board of Directors
-
Stanford University's SMILE and Spirit of Math partner to host 21st International Math Contest
-
Nektar Therapeutics (NKTR) Names Myriam J. Curet, MD to Board
-
Merus N.V. (MRUS) Reports Dr. Ton Logtenberg to Resign as CEO, President, Principal Financial Officer & Board Member
-
Akcea Therapeutics (AKCA) Announces Lynne Parshall, J.D. as Bpard Chair; Appoints Barbara Yanni to Board
-
Oncosec Medical (ONCS) Presents Interim Data of 28.5% ORR from Ongoing KEYNOTE-890 Study Evaluating TAVO in Combination with KEYTRUDA for Heavily Pretreated, Late-Stage, mTNBC
-
Salesforce (CRM) names Bret Taylor President & COO
-
Stanford Children's Health opens new inpatient cancer center and outpatient heart center--boosting capacity for specialty care
-
BeyondSpring's (BYSI) Study 106 Phase 3 Superior Trial Design Combining Plinabulin with Pegfilgrastim Versus Pegfilgrastim Alone for CIN Presented at ASH
-
Cousins Properties (CUZ) has elected RobertChapman as Non-Executive Chairman
-
ATARA Biotherapeutics (ATRA) Reports Updated L-T Clinical Results from Tab-cel Multicenter EAP Study for Patients with EBV+ PTLD at ASH
-
Abeona Therapeutics (ABEO) announced FDA has removed its clinical hold and provided clearance to proceed with the VIITAL study
-
Rocket Pharmaceuticals (RCKT) Highlights Promising Preliminary Results from Phase 1 Trial of Commercial-Grade RP-L102 'Process B' for Fanconi Anemia
-
Vail Resorts (MTN) Announces Nadia Rawlinson to Board
-
Stanford University reports FY 2019 financial results
-
Accuray (ARAY) announces Stanford University Medical Center has selected second CyberKnife M6 System
-
Stanford University Medical Center to Acquire Second Accuray CyberKnife® M6™ System

